Chemokines and eicosanoids fuel the hyperinflammation within the lungs of patients with severe COVID-19

BACKGROUND: Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection can lead to a variety of clinical outcomes, ranging from the absence of symptoms to severe acute respiratory disease and ultimately death. A feature of patients with severe coronavirus disease 2019 (COVID-19) is the a...

Descripción completa

Detalles Bibliográficos
Autores principales: Zaid, Younes, Doré, Étienne, Dubuc, Isabelle, Archambault, Anne-Sophie, Flamand, Olivier, Laviolette, Michel, Flamand, Nicolas, Boilard, Éric, Flamand, Louis
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Authors. Published by Elsevier Inc. on behalf of the American Academy of Allergy, Asthma & Immunology. 2021
Materias:
Covid-19
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8180473/
https://www.ncbi.nlm.nih.gov/pubmed/34111453
http://dx.doi.org/10.1016/j.jaci.2021.05.032

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8180473/
https://www.ncbi.nlm.nih.gov/pubmed/34111453
http://dx.doi.org/10.1016/j.jaci.2021.05.032

Ejemplares similares